Fig. 1: Phenotypic and dysmorphic features of patient 1 (A and B),...



x0 chromosome disorder :: Article Creator

Genetic Mutation

Denissenko, M. F., et al. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 274, 430–432 (1996)

Greenblatt, M. S., et al. Mutations in the P53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Research 54, 4855–4878 (1994)

International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature 409, 860–921 (2001) (link to article)

Kimchi-Sarfaty, C., et al. "Silent" polymorphism in the MDR1 gene changes substrate specificity. Science 315, 525–528 (2006)

Mulligan, L. M., et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363, 458–460 (1993) (link to article)

Nells, E., et al. PMP22 Thr (118) Met: Recessive CMT1 mutation or polymorphism? Nature 15, 13–14 (1997) (link to article)

Pearson, C. E., et al. Repeat instability: Mechanisms of dynamic mutations. Nature Reviews Genetics 6, 729–742 (2005) (link to article)

Pierce, B. A. Genetics: A Conceptual Approach (Freeman, New York, 2000)

Seidl, H., et al. Ultraviolet exposure as the main initiator of P53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis. Journal of Investigative Dermatology 117, 365–370 (2001)

Twyman, R. Mutation or polymorphism? Wellcome Trust website, http://genome.Wellcome.Ac.Uk/doc_WTD020780.Html (2003)

Viguera, E., et al. Replication slippage involves DNA polymerase pausing and dissociation. EMBO Journal 20, 2587–2595 (2001)






Comments

Popular posts from this blog

Diagnosis and management of vascular Ehlers-Danlos syndrome: Experience of the UK national diagnostic service, Sheffield | European Journal of Human Genetics

Non-invasive prenatal testing: a revolutionary journey in prenatal testing

Leukemia Overview: Symptoms, Signs, Treatment and Causes